David C. Hooper: Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones. In: Clinical Infectious Diseases. Band32, Supplement_1, 15. März 2001, S.S9–S15, doi:10.1086/319370.
Karl Drlica, Muhammad Malik, Robert J. Kerns, Xilin Zhao: Quinolone-Mediated Bacterial Death. In: Antimicrobial Agents and Chemotherapy. Band52, Nr.2, 1. Februar 2008, S.385–392, doi:10.1128/aac.01617-06, PMID 17724149.
Peter Ball: Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review. In: Current Therapeutic Research, Clinical and Experimental. Band64, Nr.9, November 2003, S.646–661, doi:10.1016/j.curtheres.2003.11.003, PMID 24944413, PMC 4053061 (freier Volltext).
Karl Drlica, Muhammad Malik, Robert J. Kerns, Xilin Zhao: Quinolone-Mediated Bacterial Death. In: Antimicrobial Agents and Chemotherapy. Band52, Nr.2, 1. Februar 2008, S.385–392, doi:10.1128/aac.01617-06, PMID 17724149.
C. Joukhadar, H. Stass, U. Müller-Zellenberg, E. Lackner, F. Kovar: Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. In: Antimicrobial Agents and Chemotherapy. Band47, Nr.10, 2003, S.3099–3103, PMID 14506015.
O. Burkhardt, T. Köhnlein u. a.: Recurrent tendinitis after treatment with two different fluoroquinolones. In: Scandinavian Journal of Infectious Diseases. Band36, Nr.4, 2004, S.315–316, PMID 15198194.
A. De Sarro, G. De Sarro: Adverse reactions to fluoroquinolones. an overview on mechanistic aspects. In: Current Medicinal Chemistry. Band8, Nr.4, März 2001, S.371–384, PMID 11172695.
Peter Ball: Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review. In: Current Therapeutic Research, Clinical and Experimental. Band64, Nr.9, November 2003, S.646–661, doi:10.1016/j.curtheres.2003.11.003, PMID 24944413, PMC 4053061 (freier Volltext).
